Post-effective amendment to a registration statement that is not immediately effective upon filing

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)

v3.22.1
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) - USD ($)
Total
Class A/B
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2018   28,497,000        
Balance, amount at Dec. 31, 2018 $ 32,640,000       $ 54,333,000 $ (21,693,000)
Net loss (49,934,000)         (49,934,000)
Adoption of lease accounting standard (847,000)         (847,000)
Issuance of subordinate voting shares in exchange for Class A/B shares, net, shares   (28,497,000) 28,497,000      
Private placement in connection with reverse takeover, net, shares     3,433,000      
Private placement in connection with reverse takeover, net, amount $ 36,762,000       36,762,000  
Shares issued to acquiree in connection with reverse takeover, shares 1,513,000   130,000      
Shares issued to acquiree in connection with reverse takeover, amount $ 1,513,000       1,513,000  
Issuance of super voting shares, shares       203,000    
Issuance of super voting shares, amount 40,000       40,000  
Share-based Compensation Expense, Shares     659,000      
Share-based Compensation Expense, Amount 3,385,000       3,385,000  
Exercise of options, shares     125,000      
Exercise of options, amount 127,000       127,000  
Balance, Shares at Dec. 31, 2019     32,844,000 203,000    
Balance, Amount at Dec. 31, 2019         96,160,000 (72,474,000)
Net loss (21,910,000)         (21,910,000)
Shares Issued In Connection With Conversion Of Convertible Debentures, Shares     375,000      
Shares Issued In Connection With Conversion Of Convertible Debentures, Amount 75,000       75,000  
Issuance Of Shares Associated With Acquisitions, Shares     150,000      
Share-based Compensation Expense, Shares     248,000      
Share-based Compensation Expense, Amount 2,200,000       2,200,000  
Shares issued in connection with convertible debenture offering, shares     250,000      
Shares issued in connection with convertible debenture offering, amount 62,000       62,000  
Shares issued in connection with subordinate voting share offering, shares     23,000,000      
Shares issued in connection with subordinate voting share offering, amount 25,021,000       25,021,000  
Issuance of stock options associated with acquisitions 116,000       116,000  
Issuance of shares associated with acquisitions, amount 179,000       179,000  
Issuance of stock warrants 1,556,000       1,556,000  
Reduction in super voting share purchase price (39,000)       (39,000)  
Exercise of warrants, shares     750,000      
Exercise of warrants, amount 210,000       210,000  
Balance, Shares at Dec. 31, 2020     57,617,000 203,000    
Balance, Amount at Dec. 31, 2020 31,156,000       125,540,000 (94,384,000)
Net loss (6,719,000)         (6,719,000)
Shares Issued In Connection With Conversion Of Convertible Debentures, Shares     1,390      
Shares Issued In Connection With Conversion Of Convertible Debentures, Amount 277       277  
Issuance Of Shares Associated With Acquisitions, Shares     22,644      
Issuance Of Shares Associated With Acquisitions, Amount 34,237       34,237  
Exercise Of Warrants, Shares     1,324      
Exercise Of Warrants, Amount 665       665  
Share-based Compensation Expense, Shares     246      
Share-based Compensation Expense, Amount 287       287  
Balance, Shares at Mar. 31, 2021     83,221,000 203,000    
Balance, Amount at Mar. 31, 2021 59,903,000       161,006,000 (101,103,000)
Balance, shares at Dec. 31, 2020     57,617,000 203,000    
Balance, amount at Dec. 31, 2020 31,156,000       125,540,000 (94,384,000)
Net loss (24,677,000)         (24,677,000)
Shares Issued In Connection With Conversion Of Convertible Debentures, Shares     2,580,000      
Shares Issued In Connection With Conversion Of Convertible Debentures, Amount 514,000       514,000  
Issuance Of Shares Associated With Acquisitions, Shares     30,641,000      
Share-based Compensation Expense, Shares     1,290,000      
Share-based Compensation Expense, Amount $ 1,355,000       1,355,000  
Exercise of options, shares 165,000   167,000      
Exercise of options, amount $ 48,000       48,000  
Issuance of shares associated with acquisitions, amount 43,259,000       43,259,000  
Exercise of warrants, shares     1,511,000      
Exercise of warrants, amount 718,000       718,000  
Issuance of shares associated with subordinate voting share offering, shares     18,000,000      
Issuance of shares associated with subordinate voting share offering, amount 17,934,000       17,934,000  
Balance, Shares at Dec. 31, 2021     111,806,000 203,000    
Balance, Amount at Dec. 31, 2021 70,307,000       189,368,000 (119,061,000)
Net loss (4,057,000)         (4,057,000)
Share-based Compensation Expense, Shares     220      
Share-based Compensation Expense, Amount $ 161       161  
Exercise of options, shares 0          
Balance, Shares at Mar. 31, 2022     112,026,000 203,000    
Balance, Amount at Mar. 31, 2022 $ 66,411,000       $ 189,529,000 $ (123,118,000)